Laurie J. Hall Trustee’s Alnylam Pharmaceuticals ALNY Stock Holding History

Laurie J. Hall Trustee’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$846K	Hold	2,812	–	–	0.26%	63
2026 Q1	$930K	Hold	2,812	–	–	0.33%	62
2025 Q4	$1.12M	Sell	2,812 -438	-13%	-$194K	0.37%	60
2025 Q3	$1.48M	Hold	3,250	–	–	0.48%	55
2025 Q2	$1.06M	Hold	3,250	–	–	0.35%	64
2025 Q1	$878K	Hold	3,250	–	–	0.31%	65
2024 Q4	$765K	Hold	3,250	–	–	0.25%	70
2024 Q3	$894K	Hold	3,250	–	–	0.28%	70
2024 Q2	$790K	Hold	3,250	–	–	0.28%	67
2024 Q1	$486K	Hold	3,250	–	–	0.17%	75
2023 Q4	$622K	Hold	3,250	–	–	0.24%	68
2023 Q3	$576K	Hold	3,250	–	–	0.25%	66
2023 Q2	$617K	Hold	3,250	–	–	0.24%	66
2023 Q1	$651K	Hold	3,250	–	–	0.28%	65
2022 Q4	$772K	Hold	3,250	–	–	0.35%	61
2022 Q3	$651K	Hold	3,250	–	–	0.32%	62
2022 Q2	$474K	Hold	3,250	–	–	0.22%	74
2022 Q1	$531K	Hold	3,250	–	–	0.2%	75
2021 Q4	$551K	Sell	3,250 -550	-14%	-$102K	0.2%	77
2021 Q3	$717K	Hold	3,800	–	–	0.28%	67
2021 Q2	$644K	Hold	3,800	–	–	0.24%	71
2021 Q1	$537K	Hold	3,800	–	–	0.21%	78
2020 Q4	$494K	Hold	3,800	–	–	0.2%	76
2020 Q3	$553K	Buy	+3,800	New	+$540K	0.25%	69
2019 Q4	$438K	Hold	3,800	–	–	0.2%	78
2019 Q3	$306K	Hold	3,800	–	–	0.16%	87
2019 Q2	$276K	Hold	3,800	–	–	0.14%	92
2019 Q1	$355K	Hold	3,800	–	–	0.19%	84
2018 Q4	$319K	Hold	3,800	–	–	0.18%	83
2018 Q3	$333K	Hold	3,800	–	–	0.18%	81
2018 Q2	$374K	Hold	3,800	–	–	0.21%	75
2018 Q1	$453K	Hold	3,800	–	–	0.28%	64
2017 Q4	$483K	Hold	3,800	–	–	0.28%	64
2017 Q3	$446K	Hold	3,800	–	–	0.28%	64
2017 Q2	$303K	Hold	3,800	–	–	0.19%	75
2017 Q1	$181K	Hold	3,800	–	–	0.12%	96
2016 Q4	$160K	Buy	+3,800	New	+$159K	0.1%	104
2016 Q2	$241K	Hold	3,800	–	–	0.16%	82
2016 Q1	$273K	Hold	3,800	–	–	0.17%	82
2015 Q4	$243K	Hold	3,800	–	–	0.18%	84
2015 Q3	$305K	Hold	3,800	–	–	0.24%	71
2015 Q2	$456K	Hold	3,800	–	–	0.33%	61
2015 Q1	$397K	Hold	3,800	–	–	0.29%	62
2014 Q4	$369K	Hold	3,800	–	–	0.26%	66
2014 Q3	$297K	Hold	3,800	–	–	0.22%	71
2014 Q2	$240K	Hold	3,800	–	–	0.18%	78
2014 Q1	$255K	Hold	3,800	–	–	0.2%	75
2013 Q4	$244K	Hold	3,800	–	–	0.19%	77
2013 Q3	$243K	Buy	+3,800	New	+$189K	0.2%	77

Other funds holding ALNY

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

PSC

Portman Square Capital London, United Kingdom $2.11B AUM 19.71% 1-Year Est. Return

PensionDanmark Copenhagen O, Denmark $12B AUM

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

Laurie J. Hall Trustee's ALNY Position: Q2 2026 in Review

Laurie J. Hall Trustee held its Alnylam Pharmaceuticals (ALNY) position steady in Q2 2026 at 2,812 shares worth $846K. The position accounts for 0.26% of the portfolio, ranked #63.

Laurie J. Hall Trustee first reported a position in ALNY in Q3 2013 and has held it in 49 quarters since. The position peaked at $1.48M in Q3 2025. 78 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Laurie J. Hall Trustee held 2,812 shares of Alnylam Pharmaceuticals worth $846K as of Q2 2026.
Laurie J. Hall Trustee left its Alnylam Pharmaceuticals share count unchanged in Q2 2026.
Alnylam Pharmaceuticals made up 0.26% of Laurie J. Hall Trustee's portfolio in Q2 2026, its #63 holding.
Laurie J. Hall Trustee first reported a position in Alnylam Pharmaceuticals in Q3 2013 and has held it in 49 quarters since.
Laurie J. Hall Trustee's Alnylam Pharmaceuticals position peaked at $1.48M in Q3 2025.
78 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Laurie J. Hall Trustee's 13F filing for Q2 2026, filed 9 Jul 2026.